[Wayne07]

I’d be surprised if the risk-averse FDA actually authorized the AZ/Oxford vaccine any time soon. The clinical trials they conducted had numerous problems in protocols and there’s at least a question (probably nothing, but the question begs to be answered) about the blood clotting reports.

The UK trial had issues (dosing error), but they US trial seems to have been problem free. If they hadn't screwed up in the UK, it probably would have been approved more quickly in the US, but it still looks on track to be approved in next month, 5 months after it was approved in the UK.

[2aProtectsTheRest]

You could very well be right. I’ll be curious to see how the FDA handles the suspension from some European countries and the issue of ineffectiveness with the South Africa variant. Personally, I just don’t see the point of approving a vaccine that doesn’t work against all variants. To me, that’s just asking for that variant to become dominant in the US among a population of people who thought they were fine because they had been vaccinated.

But hey, FDA might surprise me and just decided to issue the EUA anyway. I’ve certainly been wrong before.